UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 182

Sortiert nach

Preferential in vivo action of F15599, a novel 5‐HT1A receptor agonist, at postsynaptic 5‐HT1A receptors

British journal of pharmacology, 2010-08, Vol.160 (8), p.1929-1940

2010

Volltextzugriff (PDF)

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety

Neuropharmacology, 2013-07, Vol.70, p.338-347

2013

Volltextzugriff (PDF)

Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist

British journal of pharmacology, 2009-01, Vol.156 (2), p.338-353

2009

Volltextzugriff (PDF)

Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia

Neuropharmacology, 2002-11, Vol.43 (6), p.945

2002

Volltextzugriff (PDF)

Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels : (S)-WAY100135, but not WAY100635, has partial agonist properties

European journal of pharmacology, 1996-05, Vol.304 (1-3), p.15-22

1996

Volltextzugriff (PDF)

Rapid desensitization of somatodendritic 5‐HT1A receptors by chronic administration of the high‐efficacy 5‐HT1A agonist, F13714: a microdialysis study in the rat

British journal of pharmacology, 2006-09, Vol.149 (2), p.170-178

2006

Volltextzugriff (PDF)

Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT1A Receptors

Journal of medicinal chemistry, 1999-05, Vol.42 (9), p.1648-1660

1999

Volltextzugriff (PDF)

(-)-Pindolol and (±)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors

Neuropharmacology, 1996-02, Vol.35 (2), p.213-222

1996

Volltextzugriff (PDF)

5‐HT1A receptors are involved in the effects of xaliproden on G‐protein activation, neurotransmitter release and nociception

British journal of pharmacology, 2009-09, Vol.158 (1), p.232-242

2009

Volltextzugriff (PDF)

Possible in vivo 5‐HT reuptake blocking properties of 8‐OH‐DPAT assessed by measuring hippocampal extracellular 5‐HT using microdialysis in rats

British journal of pharmacology, 1996-11, Vol.119 (5), p.845-850

1996

Volltextzugriff (PDF)

5-HT1A receptor agonist properties of the antipsychotic, nemonapride : comparison with bromerguride and clozapine

European journal of pharmacology, 1997-09, Vol.334 (2-3), p.141-147

1997

Volltextzugriff (PDF)

In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats

Psychopharmacology, 2000-05, Vol.149 (4), p.377-387

2000

Volltextzugriff (PDF)

Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat

Neuropharmacology, 1992-02, Vol.31 (2), p.149-155

1992

Volltextzugriff (PDF)

Design and Synthesis of a Series of 6-Substituted-2-pyridinylmethylamine Derivatives as Novel, High-Affinity, Selective Agonists at 5-HT1A Receptors

Journal of medicinal chemistry, 1998-12, Vol.41 (25), p.5070-5083

1998

Volltextzugriff (PDF)

Biphasic displacement of [ 3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics

European journal of pharmacology, 1993-06, Vol.237 (2), p.183-189

1993

Volltextzugriff (PDF)

Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT 1A receptor agonist

British journal of pharmacology, 2009-01, Vol.156 (2), p.338-353

2009

Volltextzugriff (PDF)

Rapid desensitization of somatodendritic 5‐HT 1A receptors by chronic administration of the high‐efficacy 5‐HT 1A agonist, F13714: a microdialysis study in the rat

British journal of pharmacology, 2009-01, Vol.149 (2), p.170-178

2009

Volltextzugriff (PDF)

5-HT1A receptor activation and antidepressant-like effects : F 13714 has high efficacy and marked antidepressant potential

European journal of pharmacology, 2001-05, Vol.420 (2-3), p.103-112

2001

Volltextzugriff (PDF)

F15063, a potential antipsychotic with D2/D3 antagonist, 5‐HT1A agonist and D4 partial agonist properties: (I) in vitro receptor affinity and efficacy profile

British journal of pharmacology, 2007-05, Vol.151 (2), p.237-252

2007

Volltextzugriff (PDF)

Differential in vivo Inhibition of [3H]Nemonapride Binding by Atypical Antipsychotics in Rat Striatum, Olfactory Lobes, and Frontal Cortex

Pharmacology, 2005-10, Vol.75 (2), p.63-68

2005

Volltextzugriff (PDF)

Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity

European journal of pharmacology, 1999-12, Vol.386 (1), p.97-103

1999

Volltextzugriff (PDF)

F15063, a potential antipsychotic with D 2 /D 3 antagonist, 5‐HT 1A agonist and D 4 partial agonist properties: (I) in vitro receptor affinity and efficacy profile

British journal of pharmacology, 2009-01, Vol.151 (2), p.237-252

2009

Volltextzugriff (PDF)

5‐HT 1A receptors are involved in the effects of xaliproden on G‐protein activation, neurotransmitter release and nociception

British journal of pharmacology, 2009-09, Vol.158 (1), p.232-242

2009

Volltextzugriff (PDF)

F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential

The Journal of pharmacology and experimental therapeutics, 1998-10, Vol.287 (1), p.266

1998

Volltextzugriff (PDF)

In vivo [ 3H]ketanserin binding: effect of modifying synaptic serotonin levels

Neurochemistry international, 1988, Vol.12 (1), p.85-89

1988

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(178)
Mit Volltextzugriff
(169)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Male
(34)
Animals
(33)
Life Sciences & Biomedicine
(33)
Rats
(31)
Pharmacology & Pharmacy
(27)
Physics
(25)
Biological And Medical Sciences
(24)
Rats, Sprague-Dawley
(24)
Medical Sciences
(23)
Pharmacology. Drug Treatments
(21)
Endocrinology & Metabolism
(20)
Humans
(17)
Internal Medicine
(17)
Neuropharmacology
(15)
Serotonin Receptor Agonists - Pharmacology
(15)
Nuclear Experiment
(14)
Physical Sciences
(14)
Dose-Response Relationship, Drug
(13)
Physics, Nuclear
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preferential in vivo action of F15599, a novel 5‐HT1A receptor agonist, at postsynaptic 5‐HT1A receptors

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety

Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist

Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia

Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels : (S)-WAY100135, but not WAY100635, has partial agonist properties

Rapid desensitization of somatodendritic 5‐HT1A receptors by chronic administration of the high‐efficacy 5‐HT1A agonist, F13714: a microdialysis study in the rat

Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT1A Receptors

(-)-Pindolol and (±)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors

5‐HT1A receptors are involved in the effects of xaliproden on G‐protein activation, neurotransmitter release and nociception

Possible in vivo 5‐HT reuptake blocking properties of 8‐OH‐DPAT assessed by measuring hippocampal extracellular 5‐HT using microdialysis in rats

5-HT1A receptor agonist properties of the antipsychotic, nemonapride : comparison with bromerguride and clozapine

In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats

Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat

Design and Synthesis of a Series of 6-Substituted-2-pyridinylmethylamine Derivatives as Novel, High-Affinity, Selective Agonists at 5-HT1A Receptors

Biphasic displacement of [ 3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics

Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT 1A receptor agonist

Rapid desensitization of somatodendritic 5‐HT 1A receptors by chronic administration of the high‐efficacy 5‐HT 1A agonist, F13714: a microdialysis study in the rat

5-HT1A receptor activation and antidepressant-like effects : F 13714 has high efficacy and marked antidepressant potential

F15063, a potential antipsychotic with D2/D3 antagonist, 5‐HT1A agonist and D4 partial agonist properties: (I) in vitro receptor affinity and efficacy profile

Differential in vivo Inhibition of [3H]Nemonapride Binding by Atypical Antipsychotics in Rat Striatum, Olfactory Lobes, and Frontal Cortex

Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity

F15063, a potential antipsychotic with D 2 /D 3 antagonist, 5‐HT 1A agonist and D 4 partial agonist properties: (I) in vitro receptor affinity and efficacy profile

5‐HT 1A receptors are involved in the effects of xaliproden on G‐protein activation, neurotransmitter release and nociception

F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential

In vivo [ 3H]ketanserin binding: effect of modifying synaptic serotonin levels

Suchergebnisse filtern